Analytical protocol to identify local ancestry-associated molecular features in cancer
- PMID: 34585150
- PMCID: PMC8456058
- DOI: 10.1016/j.xpro.2021.100766
Analytical protocol to identify local ancestry-associated molecular features in cancer
Abstract
People of different ancestries vary in cancer risk and outcome, and their molecular differences may indicate sources of these variations. Determining the "local" ancestry composition at each genetic locus across ancestry-admixed populations can suggest causal associations. We present a protocol to identify local ancestry and detect the associated molecular changes, using data from the Cancer Genome Atlas. This workflow can be applied to cancer cohorts with matched tumor and normal data from admixed patients to examine germline contributions to cancer. For complete details on the use and execution of this protocol, please refer to Carrot-Zhang et al. (2020).
Keywords: Bioinformatics; Cancer; Genomics.
© 2021 The Author(s).
Conflict of interest statement
A.D.C. receives research funding from Bayer. R.B. owns equity in and consults for Scorpion and Ampressa Therapeutics and receives research funding from Novartis.
Figures



References
-
- Delaneau O., Marchini J., Zagury J.-F. A linear complexity phasing method for thousands of genomes. Nat. Methods. 2011;9:179–181. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 CA210978/CA/NCI NIH HHS/United States
- U24 CA210950/CA/NCI NIH HHS/United States
- U24 CA264021/CA/NCI NIH HHS/United States
- U24 CA210974/CA/NCI NIH HHS/United States
- U24 CA210989/CA/NCI NIH HHS/United States
- U24 CA210952/CA/NCI NIH HHS/United States
- U24 CA210957/CA/NCI NIH HHS/United States
- U24 CA210949/CA/NCI NIH HHS/United States
- K24 CA169004/CA/NCI NIH HHS/United States
- U24 CA210990/CA/NCI NIH HHS/United States
- U24 CA211000/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- U24 CA210969/CA/NCI NIH HHS/United States
- U24 CA210988/CA/NCI NIH HHS/United States
- U24 CA211006/CA/NCI NIH HHS/United States
- U24 CA210999/CA/NCI NIH HHS/United States